https://www.selleckchem.com/pr....oducts/asunaprevir.h
The globally increasing resistance due to extended-spectrum beta-lactamase producing is a major concern. The objective of this work was to develop a murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment and to compare the fecal carriage of ESBL-producing . SWISS mice were treated either with ceftriaxone or with cefotaxime or with NaCl 0.9% as a control group from day 1 to day 5. We performed a gavage at day 4 with a CTX-M9. We collected stools and performed pharmacolog
Like
Comment
Share
